Drug intelligence / Profile preview

sulfadiazine sodium

Development stage
Approved
Lead developer
AICA Laboratories
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Sodium sulfadiazine is the sodium salt form of sulfadiazine, a short-acting sulfonamide antibiotic. It functions as a competitive antagonist of para-aminobenzoic acid (PABA), thereby inhibiting the bacterial enzyme dihydropteroate synthase, which is essential for the synthesis of dihydrofolic acid. This inhibition disrupts the production of folic acid, a necessary precursor for bacterial DNA and RNA synthesis, leading to a bacteriostatic effect. It is primarily indicated for the treatment of infections caused by susceptible strains of organisms, including urinary tract infections, chancroid, and nocardiosis, and is used as prophylaxis for rheumatic fever and meningococcal meningitis. In pharmaceutical manufacturing, it is often produced as an injectable generic product for parenteral administration.

Other names
sodium sulfadiazinesulfadiazine sodium salt
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfadiazine sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfadiazine sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call